Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study

MLA

Larry Charleston, et al. “Persistence to Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA among Patients with Migraine: A Retrospective Cohort Study.” The Journal of Headache and Pain, vol. 24, no. 1, Aug. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s10194-023-01636-8.

APA

Larry Charleston, Brian Talon, Christine Sullivan, Carlton Anderson, Steven Kymes, Stephane A. Regnier, Seema Soni-Brahmbhatt, & Stephanie J. Nahas. (2023). Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study. The Journal of Headache and Pain, 24(1), 1–11. https://doi.org/10.1186/s10194-023-01636-8

Chicago

Larry Charleston, Brian Talon, Christine Sullivan, Carlton Anderson, Steven Kymes, Stephane A. Regnier, Seema Soni-Brahmbhatt, and Stephanie J. Nahas. 2023. “Persistence to Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA among Patients with Migraine: A Retrospective Cohort Study.” The Journal of Headache and Pain 24 (1): 1–11. doi:10.1186/s10194-023-01636-8.